$63 Million Settlement Paxil Pediatric Class Action
$63 million pediatric class action re false promotion of Paxil. Judge approves final terms of improved national pediatric paxil class action settlement – consumers get a better deal.
$40 Million Settlement Third-Party Payer Class Action
$40 million third-party payer class action re off-label promotion of Paxil. Judge approves $40 million settlement in the second phase of national pediatric paxil class action – insurance companies to be reimbursed.
$28 Million Settlement Defective Drug Class Action
$28 million Paxil defective drug class action. A class action has been brought in the US territory of Puerto Rico against UK-based drug major GlaxoSmithKline.
$10 Million Settlement Celexa-Lexapro Pediatric Class Action
$10 million pediatric class action re false promotion of Celexa and Lexapro. Babies born to women who have used Lexapro and other similar medications such as Zoloft, Celexa, Prozac, Paxil, and Symbyax are at an increased risk for birth defects.
$9 Million Settlement Drug Injury
Wisner Baum obtained a $9 million settlement on behalf of an individual who was injured by a drug.
$105 Million Settlement Pharmaceutical Settlement
Wisner Baum obtained $105 million on behalf of multiple clients involved in a pharmaceutical negligence case.
We are no longer accepting new Avandia cases.
Baum Hedlund Aristei & Goldman’s drug department is representing many individuals who were taking Avandia and suffered a heart attack or coronary artery blockage that required a stent or bypass surgery. The firm is also representing individuals who suffered from a stroke or congestive heart failure while taking the drug. Our firm has represented thousands of victims of pharmaceutical drug-induced injuries and death for more than 25 years.
Avandia was pulled from pharmacies on November 18, 2011.
Our drug team has filed Avandia lawsuits against GlaxoSmithKline. At an FDA hearing in July of 2007, FDA Scientist, David Graham, stated that he thinks Avandia should be withdrawn from the market.
FDA Adds Second Black Box Warning to Avandia for Heart Attack Risk
Baum Hedlund has extensively litigated antidepressant drug cases against Avandia maker, GlaxoSmithKline, and in the process of that litigation, has acquired a number of internal GSK documents regarding Avandia. GSK may have used a similar method for concealing known side effects of Avandia, which Baum Hedlund discovered while litigating against GSK in Paxil cases.
While representing our clients, we dig deep into drug company files to discover the truth about what the company knew about the drug’s risks, when the company knew of those risks and what efforts, if any, the company took to hide those risks. Only through legal action can anyone gain access to this type of information.
FDA Scientist Says Avandia Should be Pulled from US Market
From publicly available information, Cleveland Clinic cardiologist Dr. Steven Nissen and his colleague Kathy Wolski, found, after evaluating 42 studies that compared patients taking Avandia with patients not using the drug, that the risk of heart attack increased 43 percent among patients taking Avandia and determined that there is also a 64 percent increased risk of dying from cardiovascular causes while taking Avandia.
If you or a loved one has experienced adverse side effects after taking Avandia, Contact Baum Hedlund Aristei & Goldman today for a free consultation.
Multiple lawyers recommended Wisner Baum to me and I have been consistently impressed with the quality of their work.- Best Law Firms Survey
Wisner Baum are not only amazing attorneys but more importantly, they are activists. They are about changing the systems which got us into trouble in the first place. They understand their role in the process of making change.- Kim Witczak
The Wisner Baum firm has some of the top legal minds in the country; they are driven, determined, trustworthy, ethical and passionate.- From Best Lawyers® Best Law Firms